135 related articles for article (PubMed ID: 3295578)
21. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
22. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception.
Chou J; Tang J; Del Rio J; Yang HY; Costa E
J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138
[TBL] [Abstract][Full Text] [Related]
23. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig.
Ahrén B; Mårtensson H; Nobin A
Pancreas; 1988; 3(3):279-84. PubMed ID: 2898779
[TBL] [Abstract][Full Text] [Related]
25. Pain control by endogenous enkephalins is mediated by mu opioid receptors.
Chaillet P; Coulaud A; Fournié-Zaluski MC; Gacel G; Roques BP; Costentin J
Life Sci; 1983; 33 Suppl 1():685-8. PubMed ID: 6319920
[TBL] [Abstract][Full Text] [Related]
26. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
27. Involvement of endogenous enkephalins in the mouse 'behavioral despair' test.
Natan LB; Chaillet P; Lecomte JM; Marçais H; Uchida G; Costentin J
Eur J Pharmacol; 1984 Jan; 97(3-4):301-4. PubMed ID: 6584312
[TBL] [Abstract][Full Text] [Related]
28. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
Hoły Z; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
[TBL] [Abstract][Full Text] [Related]
29. An inhibitory action of tetracyclines on guinea-pig myenteric plexus.
Anadón A; Martinez-Larrañaga MR
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):200-3. PubMed ID: 3550480
[TBL] [Abstract][Full Text] [Related]
30. Different effects of peptidase inhibitors on dermorphin- and on [D-Arg2]dermorphin-induced antinociceptive activity.
Sakurada S; Watanabe H; Sakurada T; Kisara K; Sasaki Y; Suzuki K
Eur J Pharmacol; 1992 Jan; 211(1):75-80. PubMed ID: 1352249
[TBL] [Abstract][Full Text] [Related]
31. Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone.
Rattray M; de Belleroche J
Neuropeptides; 1987; 10(2):189-200. PubMed ID: 3683773
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of the evoked liberation of (Met5)enkephalin from slices of globus pallidus in the presence of thiorphan and bestatin].
Giros B; de la Baume S; Gros C; Schwartz JC
C R Seances Acad Sci III; 1983; 297(13):609-12. PubMed ID: 6424884
[TBL] [Abstract][Full Text] [Related]
33. Behavioral effects of cholecystokinin and its related peptides in rats.
Itoh S; Katsuura G
Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
[TBL] [Abstract][Full Text] [Related]
34. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
35. Chronotropic actions of cholecystokinin octapeptide on the rat heart.
Marker JD; Roberts ML
Regul Pept; 1988 Mar; 20(3):251-9. PubMed ID: 3363182
[TBL] [Abstract][Full Text] [Related]
36. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
Itoh S; Katsuura G; Itoh T; Morimoto T
Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
[TBL] [Abstract][Full Text] [Related]
37. Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain.
Itoh S; Takashima A; Katsuura G
Neuropharmacology; 1988 Apr; 27(4):427-31. PubMed ID: 2458532
[TBL] [Abstract][Full Text] [Related]
38. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
40. Effect of inhibition of neuropeptidases on the pain threshold of mice and rats.
Carenzi A; Frigeni V; Reggiani A; Della Bella D
Neuropharmacology; 1983 Nov; 22(11):1315-9. PubMed ID: 6363960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
